A research team at the Korea Advanced Institute of Science and Technology (KAIST) said it developed fabric-based wearable blue organic light-emitting diodes (OLEDs) that can treat jaundice in newborns.Hospitals currently treat neonatal jaundice in a variety of ways, including phototherapy, drug admi
Celltrion Healthcare said multi-country real-world data proved the effectiveness and safety of Truxima (ingredient: rituximab, CT-P10), an anticancer biosimilar, in non-Hodgkin’s lymphoma (NHL) patients. EJHaem, an international academic journal, published a study of the effectiveness and safety of
Nurses and students at nursing schools gathered in front of the National Assembly on Monday, and executives at the Korean Nurses Association (KNA) shaved their heads to show determination.Some 50,000 nurses and nursing school students chanted slogans, such as, “The National Assembly must stop partis
Takeda Pharmaceutical Korea has proven the efficacy and safety of Ninlaro, a multiple myeloma treatment (ingredient: ixazomib), in Koreans through real-world data.The study included 60 patients who received Ninlaro in combination with two other treatments (ixazomib + lenalidomide + dexamethasone) at
GSK has decided to voluntarily withdraw Juluca (dolutegravir/rilpivirine), the company’s first-ever two-drug regimen of HIV treatment, three years and nine months after it won the permit in Korea.According to the Ministry of Food and Drug Safety, GSK withdrew the permit of Juluca Tab. on Monday.Acco
Janssen Korea and Illumina Korea are considering trimming their payroll, following the moves of other Korean offshoots of multinational pharmaceutical firms.According to industry sources, Janssen Korea is trying to reduce its workforce through an early retirement program (ERP)."I have heard that our
Wells Bio, a subsidiary of Access Bio, said on Tuesday that it has recently obtained approval from the Ministry of Food and Drug Safety (MFDS) for its kit that can diagnose tsutsugamushi bacterial infections.Tsutsugamushi is an acute febrile disease transmitted by larvae of chigger mites carrying ts
It may be safe to say that the development of PARP (Poly ADP-ribose polymerase) inhibitors has changed the treatment environment for ovarian cancer. That’s because the development extended the progression-free survival period and other prognoses of ovarian cancer patients.After it was known that PAR
Seegene, a company specializing in molecular diagnostics, said it won a 62.7 billion won ($46.1 million) contract to supply its diagnostic reagents to Italy. Seegene said Italy Arrow Diagnostics S.r.l. had been selected as a supplier in the diagnostic reagent bidding, which the Tuscany government ho
Radiological Society of North America (RSNA) 2022 will kick off its five-day run at the McCormick Place Convention Center in Chicago, Ill., from Nov. 27 to Dec. 1. The conference will provide both in-person and virtual participation.RSNA is the world’s largest academic society consisting of over 48,
ImmuneMed has won the approval for the domestic clinical trial of its candidate substance for a Covid-19 cure, hzVCFG-v13 (burfiralimab).Last Friday, the Ministry of Food and Drug Safety gave the go-ahead to Korea's phase 2/3 clinical trial. The company plans to assess the efficacy and safety of the
Korea hit yet another Covid-19 related grim milestone as the total Covid-19 deaths surpassed 30,000 on Sunday.According to the Central Disease Control Headquarters, the cumulative number of deaths from Covid-19 reached 30,031 on Sunday, exceeding 30,000.The death toll reached 30,000 in about seven m
A research team at Yonsei University College of Medicine said it identified the relationship between the expression level of proteins involved in the movement of substances within cells and the severity of atopic dermatitis.The research team, led by Professors Nam Ki-teak and Park Chang-wook at the
Lunit said on Monday that it became the first software as a medical device (SaMD) company in the Asia Pacific region to earn accreditations from the UK and Europe for its artificial intelligence (AI) medical solutions.Both Lunit INSIGHT CXR and Lunit INSIGHT MMG, an AI solution for chest radiology a
As the Covid-19 pandemic weakens to an endemic, the global medical tourism industry will restore its growth momentum from 2023, a report said.According to the report, the global medical tourism industry had grown rapidly since the turn of the 2000s but fell into a slump in 2020 due to the outbreak o
Yuyu Pharmaceutical unveiled its plans to conduct U.S. and EU clinical trials for using dutasteride to treat androgenetic alopecia (AGA) during the World Congress for Hair Research 2022 held in Melbourne, Australia, from Friday to Monday.The trial aims to improve patient convenience by reducing the
Lilly Korea said on Monday that its CDK 4&6 inhibitor Verzenio (ingredient: abemaciclib) has been approved by the Ministry of Food and Drug Safety (MFDS) on Friday for an additional indication for high-risk early breast cancer.Specifically, it was approved for hospital patients with a high risk of r
Moderna started to receive recognition as a messenger RNA (mRNA) powerhouse after developing an effective Covid-19 vaccine less than a year after the Covid-19 pandemic first started.However, with the Covid-19 pandemic becoming more of an endemic than a pandemic, both industry watchers and investors
The government said it plans to stop using Moderna's monovalent Covid-19 vaccine from next month."The expiration date of the currently introduced Moderna's monovalent vaccine is Dec. 16, and we plan to stop using the vaccine in consideration of the public's demand," the Covid-19 vaccination response
The wide gap in infection control between large general hospitals and smaller medical institutions remains unchanged, according to government data.For instance, the rate of tertiary hospitals that operate infection control offices was 100 percent, but the comparable rate for smaller hospitals with 1